Holdings of Atlas Venture Life Science Advisors, LLC
· Original filing · Compare with another fund · Report an error
- Net assets
- -
- Positions
- 6 in 1 countries
- Top ten
- 100.0 % of the equity sleeve
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | KYMERA THERAPEUTICS INC | 4,578,008 | 381.3M $ | |
| 2 | DYNE THERAPEUTICS INC | 9,130,465 | 165.5M $ | |
| 3 | Sionna Therapeutics Inc | 2,995,602 | 120.1M $ | |
| 4 | Disc Medicine Inc | 1,513,875 | 96.8M $ | |
| 5 | Q32 Bio Inc | 2,092,106 | 13.4M $ | |
| 6 | Korro Bio Inc | 1,137,149 | 12.9M $ |
Sector breakdown
- Unattributed 100.0 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 100.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 100.0 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 6 | 790M $ | 100.00 % |
Cite this page
Titelia. "Holdings of Atlas Venture Life Science Advisors, LLC". https://titelia.com/en/funds/US13F1917529